Article
Mutations in genes <i>lpxL1, bamA</i> and <i>pmrB</i> impair the susceptibility of cystic fibrosis strains of <i>Pseudomonas aeruginosa</i> to murepavadin
2023-10-13
Abstract excerpt
Murepavadin is a peptidomimetic exhibiting specific inhibitory activity against Pseudomonas species. In the present study, its in vitro activity was assessed on 230 cystic fibrosis (CF) strains of P. aeruginosa isolated from twelve French hospitals, in comparison with twelve other antipseudomonal antibiotics. Although murepavadin is still in pre-clinical stage of development, 9.1% ( n =21) of the strains displ...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 21098af2-d8e6-507a-a109-f5ba93235801
- DOI
- 10.1101/2023.10.09.561565
